Neurocrine Biosciences
Price & Volume
Stats
See more52W Range | $110.25-$157.97 |
Market Cap | $11.2B |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $2.3B |
Revenue Growth (YoY) | 21.8% |
Gross Profit (12 Mos) | $1.5B |
Diluted EPS | $3.25 |
News
See moreYahoo Finance • 12 days ago
Neurocrine Biosciences Board of Directors Authorizes $500 Million Share Repurchase Program
Yahoo Finance • 25 days ago
Here’s Why Neurocrine Biosciences Inc. (NBIX) Crashed on Friday
Yahoo Finance • 27 days ago
Neurocrine Crumbles On Lackluster Guidance For Its Bread-And-Butter Drug
Yahoo Finance • last month
Neurocrine Obtains Exclusive Rights For Depression Drug, Takeda Reacquires Japan Rights
About
CEO | Mr. Kyle W. Gano Ph.D. |
Address | 12780 El Camino Real, San Diego, CA, United States, 92130 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 1,800 |
